sábado, 1 de octubre de 2022

Prostate cancer: conventional and stereotactic body radiotherapy show similar 2-year toxicity

Prostate cancer: conventional and stereotactic body radiotherapy show similar 2-year toxicity

No hay comentarios:

Publicar un comentario